Flunarizine: A Possible Adjuvant Medication Against Soman Poisoning?

References

• Baethmann A., Jansen M. Possible role of calcium entry blockers in brain protection. Eur. Neurol. 1986; 25(1)102–114, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Bebin M., Bleck T. P. New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol. Drugs 1994; 48: 153–171, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bodjarian N., Carpentier P., Blanchet G., Baubichon D., Lallement G. Cholinergic activation of phosphoinositide metabolism during soman‐induced seizures. NeuroReport 1993; 4: 1191–1193, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Carpentier P., Foquin‐Tarricone A., Bodjarian N., Rondouin G., Lerner Natoli M., Kamenka J. M., Blanchet G., Denoyer M., Lallement G. Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. Neurotoxicology 1994; 15: 837–851, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Carpentier P., Foquin A., Rondouin G., Lerner Natoli M., de Groot D. M.G., Lallement G. Effects of atropine sulphate on seizure activity and brain damage produced by soman in guinea‐pigs: ECoG correlates of neuropathology. Neurotoxicology 2000; 21: 521–540, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Carpentier P., Foquin A., Kamenka J. M., Rondouin G., Lerner‐Natoli M., De Groot D. M.G., Lallement G. Effects of thienylphencyclidine (TCP) on seizure activity and brain damage produced by soman in guinea‐pigs: ECoG correlates of neurotoxicity. Neurotoxicology 2001; 22: 13–28, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Carvalho C. M., Santos S. V., Carvalho A. P. Gamma‐Aminobutyric acid release from synaptosomes as influenced by Ca2− and Ca2− channel blockers. Eur. J. Pharmacol. 1986; 131: 1–12, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cousin M. A., Nicholls D. G., Pocock J. M. Flunarizine inhibits both calcium‐dependent and ‐independent release of glutamate from synaptosomes and cultured neurons. Brain Res. 1993; 606: 227–236, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Czyrak A., Mogilnicka E., Maj J. Some central pharmacological effects of the calcium channel antagonist flunarizine. J. Neural. Transm., Gen. Sect. 1991; 83: 179–188
   PubMed Web of Science ®Google Scholar
• De Sarro G., De Sarro A., Federico F., Meldrum B. S. Anticonvulsant properties of some calcium antagonists on sound‐induced seizures in genetically epilepsy prone rats. Gen. Pharmacol. 1990; 21: 769–778, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Dobric S., Milovanovic S. R. The protective efficacy of calcium channel blockers in soman‐poisoned rats. ASA ed. Third CB Medical Treatment Symposium ASA. Spiez, Switzerland 2000; 49
   Google Scholar
• Dretchen K. L., Bowles A. M., Raines A. Protection by phenytoin and calcium channel blocking agents against the toxicity of diisopropylfluorophosphate. Toxicol. Appl. Pharmacol. 1986; 83: 584–589, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gasior M., Kaminski R., Brudniak T., Kleinrok Z., Czuczwar S. J. Influence of Nicardipine, Nimodipine and Flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice. J. Neural. Transm., Gen. Sect. 1996; 103: 819–831
   Web of Science ®Google Scholar
• Gasior M., Borowicz K., Kleinrok Z., Starownik R., Czuczwar S. J. Anticonvulsant and adverse effects of MK‐801, LY 235959, and GYKI 52466 in combination with Ca2∣channel inhibitors in mice. Pharmacol. Biochem. Behav. 1997; 56: 629–635, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hamilton M. G., Posavad C. Alteration of calcium influx in rat cortical synaptosomes by soman. NeuroReport 1991; 2: 273–276, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hoskins B., Liu D. D., Ho I. K. Acute effects of soman, sarin, and tabun on microsomal and cytosolic components of the calmodulin system in rat striatum. J. Neurochem. 1986; 46: 265–269, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hunter A. J. Calcium antagonists: their role in neuroprotection. Neuroprotective Agents and Cerebral Ischaemia, A. R. Green, A. J. Cross. Academic Press, San Francisco 1997; Vol. 40: 95–108
   Google Scholar
• Karler R. L.D., Calder S. A., Turkanis S. A. Calcium channel blockers and excitatory amino acids. Brain Res. 1991; 551: 331–333, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Karlsson B. M., Waara L. M., Fredriksson S. A., Koskinen L. O.D. The effect of calcium antagonist nimodipine on the detoxification of soman in anaesthetized rabbits. J. Pharm. Pharmacol. 1997; 49: 296–300, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Karlsson B. M., Koch M., Koskinen L. O.D. Effects of soman in animals pretreated with nimodipine. 6th CBW protection symposium. FOA, StockholmSweden 1998
   Google Scholar
• Kauffman F. C., Davis L. H., Whittaker M. Release of Intracellular Calcium: A Novel Action of Organophosphates. US Army Medical Defense Bioscience Review, Baltimore 1987; 115–122
   Google Scholar
• Lallement G., Carpentier P., Collet A., Pernot‐Marino I., Baubichon D., Blanchet G. Effects of soman‐induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res. 1991a; 563: 234–240, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lallement G., Carpentier P., Collet A., Pernot‐Marino I., Baubichon D., Blanchet G. Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: An autoradiographic study. Neurotoxicology 1991b; 12: 655–664, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lallement G., Carpentier P., Collet A., Baubichon D., Pernot‐Marino I., Blanchet G. Extracellular acetylcholine changes in rat limbic structures during soman‐induced seizures. Neurotoxicology 1992; 13: 557–567, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lallement G., Pernot‐Marino I., Foquin‐Tarricone A., Baubichon D., Piras A., Blanchet G., Carpentier P. Antiepileptic effects of NBQX against soman‐induced seizures. NeuroReport 1994; 5: 425–428, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lallement G., Dorandeu F., Filliat P., Carpentier P., Baille V., Blanchet G. Medical management of organophosphate‐induced seizures. J. Physiol. Paris 1998; 92: 369–373, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lallement G., Baubichon D., Clarencon D., Galonnier M., Peoch M., Carpentier P. Review of the value of gacyclidine (GK‐11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman. Neurotoxicology 1999; 20: 675–684, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Li J. T., Ruan J. X., Yuan S. L., Zhang Z. Q., Song Z. Y., Wang X. Y. Influence of nimodipine on elimination of soman in rabbit blood and distribution of [3H] soman in mice. Acta Pharm. Sin. 2002; 23: 937–941, [CSA]
   PubMed Web of Science ®Google Scholar
• Martin L. J., Doebler J. A., Shih T. M., Anthony A. Protective effect of diazepamepam pretreatment on soman‐induced brain lesion formation. Brain Res. 1985; 325: 287–289, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McDonald R. L. Antiepileptic drug actions on neurotransmitter receptors and ion channels. Neurotransmitters and Epilepsy, R. S. Fisher, J. T. Coylem. Wiley‐Liss Inc., New York 1991; Vol. 11: 231–245
   Google Scholar
• McDonough J. H., Shih T. M. Neuropharmacological mechanisms of nerve agent‐induced seizure and neuropathology. Neurosci. Biobehav. Rev. 1997; 21: 559–579, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• McDonough J., Jr., Jaax N. K., Crowley R. A., Mays M. Z., Modrow H. E. Atropine and/or diazepamepam therapy protects against soman‐induced neural and cardiac pathology. Fundam. Appl. Toxicol. 1989; 13: 256–276, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Meyer F. B., Anderson R. E., Sundt T. M., Jr., Sharbrough F. W. Selective central nervous system calcium channel blockers a new class of anticonvulsant agents. Mayo Clin. Proc. 1986; 61: 239–247, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• O'Neill S. K., Bolger G. T. Anticonvulsant activity of MK‐801 and nimodipine alone and in combination against pentylenetetrazole and strychnine. Pharmacol. Biochem. Behav. 1989; 32: 595–600, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Overweg J., Binnie C. D. Flunarizine, a useful adjuvant for therapy‐resistant epilepsy patients. Cerebral Ischemia and Calcium, A. Hartmann, W. Kuschinsky. Springer‐Verlag, Berlin 1989; 462–469
   Google Scholar
• Pauwels P. J., Leysen J. E., Janssen P. A. Ca− and Na− channels involved in neuronal cell death. Protection by flunarizine. Life Sci. 1991; 48: 1881–1893, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Raines A., Henderson T. R., Dretchen K. L. Effects of calcium channel blocking agents on neostigmine‐induced fasciculations. Eur. J. Pharmacol. 1989; 173: 11–17, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Serra M., Dazzi L., Caddeo M., Floris C., Biggio G. Reversal by flunarizine of the decrease in hippocampal acetylcholine release in pentylenetetrazole‐kindled rats. Biochem. Pharmacol. 1999; 58: 145–149, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Shih T. M., McDonough J. H. Pharmacological antagonism of nerve agent‐induced seizures. Proceedings of the 1996 Medical Defence Bioscience Review USAMRICD. Aberdeen Proving Ground, Maryland 1996; Vol. 1: 435–446
   Google Scholar
• Shih T. M., Koviak T. A., Capacio B. R. Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci. Biobehav. Rev. 1991; 15: 349–362, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Staneva‐Stoytcheva D., Danchev N., Popov P. Changes in benzodiazepamepine receptors of rat brain after long‐term treatment with the Ca(2 −)‐antagonists nifedipine, verapamil, flunarizine and with the calmodulin antagonist trifluoperazine. Gen. Pharmacol. 1991; 22: 1151–1154, [CSA]
   PubMedGoogle Scholar
• Starreveld E., De Beukelaar F., Wilson A. F., McLean D. R., Findlay H. P. Double‐blind cross‐over placebo controlled study of flunarizine in patients with therapy resistant epilepsy. Can. J. Neurol. Sci. 1989; 16: 187–190, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sun M. C., Chang Z. G., Shau M. Z., Huang R. H., Chou T. C. The mechanism of aging of phosphonylated acetylcholinesterase. Eur. J. Biochem. 1979; 100: 527–530, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Taylor P. Anticholinesterase agents. The Pharmacological Basis of Therapeutics, A. G. Gilman, L. S. Goodman, T. W. Rall, F. Murad. Macmillan, New York 1985; 110–129
   Google Scholar
• Tytgat J., Pauwels P. J., Vereecke J., Carmeliet E. Flunarizine inhibits a high‐threshold inactivating calcium channel (N‐type) in isolated hippocampal neurons. Brain Res. 1991; 549: 112–117, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Van Reempts J., Haseldonckx M., van Deuren B., Wouters L., Borgers M. Structural damage of the ischemic brain: involvement of calcium and effects of postischemic treatment with calcium entry blockers. Drug Dev. Res. 1986; 8: 387–395
   Web of Science ®Google Scholar
• Wachtel R. E. Effects of diltiazem and verapamil on responses to acetylcholine. Br. J. Pharmacol. 1987; 92: 561–566, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wauquier A., Ashton D., Glincke G., Fransen J., Gillardon J. M., Janssen P. A.J. Anticonvulsant profile of flunarizine. Drug Dev. Res. 1986; 7: 49–60
   Web of Science ®Google Scholar